IO Biotech (IOBT) entered into a loan facility of up to EUR 57.5M from the European Investment Bank. The debt facility includes three committed tranches totaling up to EUR 37.5M, which will become available if the company satisfies certain conditions, and one uncommitted accordion tranche of EUR 20M. The company expects the first two tranches to be available for disbursement in the first quarter of 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOBT:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue